Risk factors for anticoagulant-related bleeding in cancer: traditional and cancer-specific factors
Abstract: Managing anticoagulant therapy in cancer-associated venous thromboembolism (VTE) is challenging due to risks of recurrent VTE and anticoagulant-related bleeding. Existing clinical risk models for bleeding are limited by discriminatory ability in patients with cancer, perhaps due to the omi...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2026-02-01
|
| Reeks: | Blood Vessels, Thrombosis & Hemostasis |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S2950327225000737 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|